Filing Details

Accession Number:
0001140361-10-010440
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-05 12:00:00
Reporting Period:
2010-03-03
Filing Date:
2010-03-05
Accepted Time:
2010-03-05 19:06:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
350907 Thoratec Corp THOR Electromedical & Electrotherapeutic Apparatus (3845) 942340464
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1218700 Lawrence Cohen 6035 Stoneridge Drive
Pleasanton CA 94588
Division President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-03-03 4,643 $0.00 32,329 No 4 A Direct
Common Stock Acquisiton 2010-03-04 20,000 $12.45 52,329 No 4 M Direct
Common Stock Disposition 2010-03-04 20,000 $30.50 32,329 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Acquisiton 2010-03-03 13,929 $0.00 13,929 $29.81
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2010-03-04 20,000 $0.00 20,000 $12.45
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
13,929 2011-03-03 2020-03-03 No 4 A Direct
47,387 2004-10-14 2014-04-14 No 4 M Direct
Footnotes
  1. Options and restricted stock units were granted pursuant to the Company's equity incentive plan with no payments received for either.
  2. Represents restricted stock units. Each restricted stock unit represents a right to receive one share of Thoratec Corporation common stock upon vesting. The restricted stock units vest in four equal annual installments commencing one year after the grant date.
  3. Options vest in four equal annual installments commencing one year after the grant date.
  4. Options exercised and shares of Common Stock sold pursuant to a Sales Plan established by the Reporting Person on August 10, 2009, which Sales Plan is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Securities Exchange Act of 1934, as amended.
  5. Options vest in six equal installments commencing 6 months after the grant date.